PHILIPS NV |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.25 EUR | +0.64% |
|
+3.70% | +19.75% |
| Sales 2024 * | 18.7B 20.36B 1,604B | Sales 2025 * | 19.67B 21.42B 1,687B | Capitalization | 24.02B 26.16B 2,061B |
|---|---|---|---|---|---|
| Net income 2024 * | 189M 206M 16.21B | Net income 2025 * | 1.15B 1.25B 98.32B | EV / Sales 2024 * | 1.55 x |
| Net Debt 2024 * | 4.93B 5.37B 423B | Net Debt 2025 * | 4.62B 5.03B 396B | EV / Sales 2025 * | 1.46 x |
| P/E ratio 2024 * |
125
x | P/E ratio 2025 * |
22.6
x | Employees | 69,656 |
| Yield 2024 * |
3.37% | Yield 2025 * |
3.55% | Free-Float | 83.91% |
More Fundamentals
* Assessed data
More news
Latest transcript on Philips NV
More recommendations
More news
| 1 day | +0.64% | ||
| 1 week | +3.70% | ||
| 1 month | +30.19% | ||
| 3 months | +33.85% | ||
| 6 months | +30.29% | ||
| Current year | +19.75% |
1 week
24.60
25.58
1 month
18.5829.10
Current year
18.0929.10
1 year
16.4829.10
3 years
11.6145.16
5 years
11.6148.80
10 years
11.6148.80
| Managers | Title | Age | Since |
|---|---|---|---|
Roy Jakobs
CEO | Chief Executive Officer | 50 | 31/12/09 |
| Director of Finance/CFO | 62 | 31/12/86 | |
Shez Partovi
CTO | Chief Tech/Sci/R&D Officer | 57 | 21/03/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 31/12/14 |
Sanjay Poonen
BRD | Director/Board Member | 55 | 31/12/21 |
| Director/Board Member | 68 | 30/04/21 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.00% | 304 M€ | +16.75% | ||
| 1.41% | 14 M€ | -3.17% | ||
| 0.99% | 17 M€ | +7.97% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/05/24 | 25.25 | +0.64% | 1,277,735 |
| 14/05/24 | 25.09 | -0.59% | 2,175,805 |
| 13/05/24 | 25.24 | +1.45% | 3,276,868 |
| 10/05/24 | 24.88 | +1.26% | 3,679,276 |
| 09/05/24 | 24.57 | +0.90% | 3,420,173 |
Real-time Euronext Amsterdam, May 15, 2024 at 04:35 pm
More quotes
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
25.25
EUR
Average target price
25.87
EUR
Spread / Average Target
+2.46%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +19.75% | 24.54B | |
| +12.85% | 227B | |
| +13.88% | 192B | |
| +18.39% | 136B | |
| +28.78% | 108B | |
| +1.67% | 64.07B | |
| +18.24% | 52.1B | |
| +7.04% | 51.87B | |
| +10.83% | 44.33B | |
| +5.94% | 36.75B |
- Stock Market
- Equities
- PHIA Stock
